Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis

Shenmai injection (SMI), as a patented traditional Chinese medicine, is extracted from Panax ginseng and Ophiopogon japonicus. It commonly used in the treatment of cardiovascular disease and in the control of cardiac toxicity induced by doxorubicin (DOX) treatment. However, its anti-cardiotoxicity m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Li, Jinghao, Wang, Qilong, Zhao, Xin, Yang, Dongli, Niu, Lu, Yang, Yanze, Zheng, Xianxian, Hu, Limin, Li, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289952/
https://www.ncbi.nlm.nih.gov/pubmed/32581790
http://dx.doi.org/10.3389/fphar.2020.00815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289952/
https://www.ncbi.nlm.nih.gov/pubmed/32581790
http://dx.doi.org/10.3389/fphar.2020.00815

Ejemplares similares